Maria‐Genalin Angelo

Statistics

Publications

Citations

223

H-Index

Active since

2014

Affiliations

GlaxoSmithKline (Belgium)(Current)

Maria‐Genalin Angelo is an author at GlaxoSmithKline (Belgium) specializing in vaccinology, adverse events following immunization, and vaccine safety.

ORCID

Publications per year

2014–2017

Publications

Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme

Maria‐Genalin Angelo, Marie‐Pierre David, Julia Zima et al. · Pharmacoepidemiology and Drug Safety · 2014 · 94 citations · Full text

Veterinary Medicine, Infectious Diseases, Obstetrics +15

Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom

Corinne Willame, Dominique Rosillon, Julia Zima et al. · Human Vaccines & Immunotherapeutics · 2016 · 54 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial

Matti Lehtinen, Tiina Eriksson, Dan Apter et al. · Human Vaccines & Immunotherapeutics · 2016 · 32 citations · Full text

Medicine, Child Health, Pediatrics +16

Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data

Frank Huygen, Kristin Verschueren, Jens‐Ulrich Stegmann et al. · EBioMedicine · 2015 · 22 citations · Full text

Medicine, Preventive Medicine, Immunization +16

Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine

Marta López‐Fauqued, Julia Zima, Maria‐Genalin Angelo et al. · Vaccine · 2017 · 21 citations · Full text

Medicine, Maternal Health, Obstetrics +17

1–5 of 5